1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models

• Francesco Marincola,
• Melissa Myint,
• Monika Pradhan,
• Jeffrey Lauer,
• Christopher R Shaler,
• Sabin Dhakal,
• Yeon Sook Choi,
• Pathricia V Tilstam,
• Aesha Upadhyay,
• Daniela Maiz,
• Jeremy Fung,
• Jingzang Tao Miu,
• Carlos Sanmarco,
• Erik Hett,
• Volker Herrmann

Affiliations

Francesco Marincola

3Sonata Therapeutics, Half Moon Bay, CA, USA

Melissa Myint

1Sonata Therapeutics, Watertown, MA, USA

Monika Pradhan

1Sonata Therapeutics, Watertown, MA, USA

Jeffrey Lauer

1Sonata Therapeutics, Watertown, MA, USA

Christopher R Shaler

1Sonata Therapeutics, Watertown, MA, USA

Sabin Dhakal

2Sonata Therapeutics, Brookline, MA, USA

Yeon Sook Choi

1Sonata Therapeutics, Watertown, MA, USA

Pathricia V Tilstam

1Sonata Therapeutics, Watertown, MA, USA

Aesha Upadhyay

1Sonata Therapeutics, Watertown, MA, USA

Daniela Maiz

1Sonata Therapeutics, Watertown, MA, USA

Jeremy Fung

1Sonata Therapeutics, Watertown, MA, USA

Jingzang Tao Miu

1Sonata Therapeutics, Watertown, MA, USA

Carlos Sanmarco

1Sonata Therapeutics, Watertown, MA, USA

Erik Hett

1Sonata Therapeutics, Watertown, MA, USA

Volker Herrmann

1Sonata Therapeutics, Watertown, MA, USA